RNRMarketResearch.com

Glycomics-Glycobiology Market Global Forecast to 2021 studding Enzymes Glycoproteins Diagnostic and Drug Discovery

Press Release   •   Feb 21, 2017 05:12 EST

The report "Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021"projectsa compound annual growth of13.3%. The market to Hit USD 1,211.4 million by 2021

The report enriches both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms, garner a higher market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Browse 91 market data tables and 32 figures spread through 158 pages and in-depth TOC on “Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021" http://www.rnrmarketresearch.com/glycobiologyglycomics-market-by-product-enzymes-glycosyltransferase-neuraminidase-glycosidase-instruments-hplc-mass-spectrometry-maldi-tof-kits-and-reagents-application-immunology-onc-market-report.html

The report provides insights on the following pointers:

Market Penetration: The report provides Comprehensive information on product portfolios of the top players in the glycomics/glycobiology market. The report analyzes the glycomics/glycobiology by product, application, end user, and region

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in theglycomics/glycobiology market

Competitive Assessment: In-depth assessment of the market strategies, regional and business segments, and product portfolios of the leading players in the glycomics/glycobiology market

Market Development:The report provides Comprehensive information about the lucrative emerging markets. The report analyzes the market for various glycomics/glycobiology offerings across regions

Market Diversification: Exhaustive information about new products and services, untapped regions, recent developments, and investments in the glycomics/glycobiology market

The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast period. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of this market.

The global glycomics/glycobiology market is broadly segmented into product, application, end user, and region. On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. In 2016, the enzymes segment is expected to account for the largest share of the global glycomics/glycobiology market. The enzymes segment is further categorized into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes. In 2016, the glycosidases segment is expected to account for the largest share of the market owing to its consumable nature, vast applications of glycosidase enzymes in R&D, and drug development processes.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

For Sample copy of this Report: http://www.rnrmarketresearch.com/contacts/request-sample?rname=216467

Apart from comprehensive regional and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on the key players in the glycomics/glycobiology market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, regional focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

On the basis of region, the market was dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). In 2015, North America accounted for the largest share of the market, while Asia witnessed the highest growth rate mainly due to increasing commercialization of pharmaceutical and biotechnology research, increasing awareness about personalized medicine, and rising importance of companion diagnostics.

Major players in the glycomics/glycobiology market include are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Markets Definition
1.3 Markets Covered
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Market Scope
1.6 Market Stakeholders

2 Research Methodology
2.1 Glycomics Market Size Estimation
2.2 Glycomics Market Breakdown and Data Triangulation
2.3 Glycomics Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Glycomics: Market Overview (2016-2021)
4.2 Geographic Analysis: Glycomics Market, By Product
4.3 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
5.2.1.1 Growth of the Proteomics Market
5.2.1.2 Technological Advancements in Glycomics Instrumentation
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation Hinders Entry of New Players to the Market
5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
5.2.3 Opportunities
5.2.3.1 Increased Use of Personalized Medicine
5.2.3.2 Biomarker Identification
5.2.3.3 Developing Countries and Emerging Markets
5.2.4 Challenges
5.2.4.1 High Costs of Tools & Instruments and Their Maintenance

6 Glycomics Market, By Product
6.1 Introduction
6.2 Enzymes
6.2.1 Glycosidases
6.2.2 Glycosyltransferases
6.2.3 Neuraminidases
6.2.4 Sialyltransferases
6.2.5 Other Glycomics Enzymes
6.3 Instruments
6.3.1 Antibody Arrays
6.3.2 HPLC
6.3.3 Lectin Arrays
6.3.4 MALDI-TOF
6.3.5 Mass Spectrometers
6.3.6 Other Glycomics Instruments
6.4 Kits
6.4.1 Glycan Labeling Kits
6.4.2 Glycan Purification Kits
6.4.3 Glycan Release Kits
6.4.4 Other Glycomics Kits
6.5 Reagents
6.5.1 Glycoproteins
6.5.2 Monosaccharides
6.5.3 Oligosaccharides
6.5.4 Other Reagents

7 Glycomics Market, By Application
7.1 Introduction
7.2 Diagnostics
7.3 Drug Discovery & Development
7.4 Oncology
7.5 Immunology
7.6 Other Applications

8 Glycomics Market, By End User
8.1 Introduction
8.2 Academic Research Institutes
8.3 Pharmaceutical & Biotechnology Companies
8.4 Contract Research Organizations

9 Glycomics Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 RoE
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World (RoW)
9.5.1 South America
9.5.2 Middle East and Africa
9.5.3 Pacific and Oceania

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.2.1 Glycomics Enzymes, Kits, and Regents
10.2.2 Glycomics Instruments
10.3 Competitive Situation and Trends
10.3.1 Product Launches
10.3.2 Expansions
10.3.3 Agreements
10.3.4 Acquisitions, Collaborations, Approvals, and Others

11 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Introduction
11.2 Merck KGaA
11.3 Takara Bio, Inc.
11.4 Shimadzu Corporation
11.5 Bruker Corporation
11.6 Waters Corporation
11.7 New England Biolabs Inc.
11.8 Agilent Technologies, Inc.
11.9 Danaher Corporation
11.10 ProZyme, Inc.
11.11 Thermo Fisher Scientific, Inc.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables

Table 1 Glycomics Market Summary
Table 2 Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 3 Glycomics Enzymes Market Size, By Product, 2014–2021 (USD Million)
Table 4 Glycomics Enzymes Market Size, By Region, 2014-2021 (USD Million)
Table 5 Glycosidases Market Size, By Region, 2014-2021 (USD Million)
Table 6 Glycosyltransferases Market Size, By Region, 2014-2021 (USD Million)
Table 7 Neuraminidases Market Size, By Region, 2014-2021 (USD Million)
Table 8 Sialyltransferases Market Size, By Region, 2014–2021 (USD Million)
Table 9 Other Glycomics Enzymes Market Size, By Region, 2014–2021 (USD Million)
Table 10 Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 11 Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 12 Antibody Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 13 HPLC Market Size, By Region, 2014–2021 (USD Million)
Table 14 Lectin Arrays Market Size, By Region, 2014–2021 (USD Million)
Table 15 MALDI-TOF Market Size, By Region, 2014–2021 (USD Million)
Table 16 Mass Spectrometry Market Size, By Region, 2014–2021 (USD Million)
Table 17 Other Glycomics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 18 Glycomics Kits Market Size, By Type, 2014-2021 (USD Million)
Table 19 Glycomics Kits Market Size, By Region, 2014-2021 (USD Million)
Table 20 Glycan Labeling Kits Market Size, By Region, 2014–2021 (USD Million)
Table 21 Glycan Purification Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 Glycan Release Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 Other Glycobiology Kits Market Size, By Region, 2014-2021 (USD Million)
Table 24 Glycobiology Reagents Market Size, By Type, 2014-2021 (USD Million)
Table 25 Glycobiology Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 26 Glycoproteins Market Size, By Region, 2014–2021 (USD Million)
Table 27 Monosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 28 Oligosaccharides Market Size, By Region, 2014–2021 (USD Million)
Table 29 Other Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 30 Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 31 Glycomics Market Size for Diagnostics, By Region, 2014–2021 (USD Million)
Table 32 Glycomics Market Size for Drug Discovery and Development, By Region, 2014–2021 (USD Million)
Table 33 Glycomics Market Size for Oncology, By Region, 2014–2021 (USD Million)
Table 34 Glycomics Market Size for Immunology, By Region, 2014–2021 (USD Million)
Table 35 Glycomics Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 36 Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 37 Glycomics Market Size for Academic Research Institutes, By Region, 2014–2021 (USD Million)
Table 38 Glycomics Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 39 Glycomics Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 40 Glycomics Market Size, By Region, 2014–2021 (USD Million)
Table 41 North America: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 42 North America: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 43 North America: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 44 North America: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 45 North America: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 46 North America: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 47 North America: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 48 North America: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 49 U.S.: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 50 Canada: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 51 Europe: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 52 Europe: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 53 Europe: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 54 Europe: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 55 Europe: Glycobiology Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 56 Europe: Glycobiology Kits Market Size, By Type, 2014–2021 (USD Million)
Table 57 Europe: Glycobiology Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 59 Germany: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 60 France: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 61 U.K.: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 62 Italy: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 63 Spain: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoE: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 65 Asia: Glycomics Market Size, By Country, 2014–2021 (USD Million)
Table 66 Asia: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 67 Asia: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 68 Asia: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 69 Asia: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 70 Asia: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 71 Asia: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 72 Asia: Glycomics Market Size, By Application, 2014–2021 (USD Million)
Table 73 China: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 75 India: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 76 Roa: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 77 RoW: Glycomics Market Size, By Region, 2014–2021 (USD Million)
Table 78 RoW: Glycomics Market Size, By End User, 2014–2021 (USD Million)
Table 79 RoW: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 80 RoW: Glycomics Enzymes Market Size, By Type, 2014–2021 (USD Million)
Table 81 RoW: Glycomics Instruments Market Size, By Type, 2014–2021 (USD Million)
Table 82 RoW: Glycomics Kits Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Glycomics Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 84 RoW: Glycobiology Market Size, By Application, 2014–2021 (USD Million)
Table 85 South America: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 86 Middle East and Africa: Glycobiology Market Size, By Product, 2014–2021 (USD Million)
Table 87 Pacific and Oceania: Glycomics Market Size, By Product, 2014–2021 (USD Million)
Table 88 Product Launches, 2013–2016
Table 89 Expansions, 2013-2016
Table 90 Agreements, 2013–2016
Table 91 Acquisitions, Collaborations, Approvals, and Others, 2013–2016

List of Figures

Figure 1 Global Glycomics Market
Figure 2 Research Methodology
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Break Down of Primary Interviews: By Company Type, Designation, & Region
Figure 6 Data Triangulation Methodology
Figure 7 Enzymes to Register the Highest CAGR Between 2016 & 2021
Figure 8 Glycosidases to Dominate the Glycomics Enzymes Market in 2016
Figure 9 Mass Spectrometry to Grow at the Highest Rate During the Forecast Period
Figure 10 Glycan Release Kits to Dominate the Glycomics Kits Market in 2016
Figure 11 Oligosaccharides to Command the Largest Share of the Glycomics Reagents Market in 2016
Figure 12 Increasing Funding in Glycomics and Proteomics Research to Drive the North American Glycomics Market
Figure 13 Increasing Funding for Proteomics & Glycomics Research is an Important Growth Driver for the Glycomics Market
Figure 14 Enzymes to Account for the Largest Product Segment of the Glycomics Market in 2016
Figure 15 Asia to Register the Highest CAGR During the Forecast Period
Figure 16 Asia Holds Lucrative Growth Opportunities for Glycomics Products During the Forecast Period
Figure 17 Increasing Government and Private Funding for Proteomics and Glycobiology Research to Drive the Demand for Glycobiology Products
Figure 18 Glycomics Market in Asia to Register Highest Growth During the Forecast
Figure 19 North America: Glycomics Market Snapshot
Figure 20 Asia: Glycomics Market Snapshot
Figure 21 Key Developments in the Global Glycomics Market, 2013–2016
Figure 22 Global Glycomics Enzymes, Kits, and Reagents Market Share Analysis, By Key Player, 2015
Figure 23 Battle for Market Share: Product Launches is the Key Strategy Adopted By Players in the Glycomics Market Between 2013 & 2016
Figure 24 Geographic Revenue Mix of Top 5 Market Players
Figure 25 Merck KGaA: Company Snapshot (2015)
Figure 26 Takara Bio, Inc.: Company Snapshot (2015)
Figure 27 Shimadzu Corporation: Company Snapshot (2015)
Figure 28 Bruker Corporation: Company Snapshot (2015)
Figure 29 Waters Corporation: Company Snapshot (2015)
Figure 30 Agilent Technologies, Inc.: Company Snapshot (2015)
Figure 31 Danaher Corporation Company Snapshot (2015)
Figure 32 Thermo Fisher Scientific, Inc.: Company Snapshot (2015)